Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe revision label on the page was updated from Revision: v3.6.3 to Revision: v3.6.4. This indicates a minor post-publication update to the page's documentation and does not modify trial details or participant information.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page shows a new revision tag, updating the version from v3.6.2 to v3.6.3, reflecting a small administrative update to the page. It does not alter the substantive content of the study record.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2, indicating a recent update to the site's content or framework. This change does not alter the primary study information displayed on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedAdds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment header formatting, plus a revised version tag (Revision: v3.6.0). It also states that the study is no longer recruiting participants.SummaryDifference0.3%

- Check51 days agoChange DetectedThe revision tag on the page changes from v3.5.4 to v3.5.5, indicating a software/maintenance update to the site. It does not modify study content or other user-visible information.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a backend/metadata change. There is no indication of changes to the visible content or layout.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.